Type | Public | |
Founded | 2008 | |
HQ | Bryan, TX, US | Map |
Website | ibioinc.com | |
Employee Ratings |
USD | |
---|---|
Revenue (Q3, 2022) | 1.9m |
Gross profit (Q3, 2022) | 1.9m |
Net income (Q3, 2022) | (12.4m) |
EBIT (Q3, 2022) | (12.2m) |
Market capitalization (26-Jul-2022) | 51.3m |
Closing stock price (26-Jul-2022) | 0.2 |
Cash (31-Mar-2022) | 33.8m |
USD | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 | Q1, 2022 | Q2, 2022 | Q3, 2022 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 45.0k | 651.0k | 527.0k | 108.0k | 314.0k | 96.0k | 410.0k | 705.0k | 765.0k | 211.0k | 168.0k | 1.9m |
Cost of goods sold | 493.0k | 40.0k | 113.0k | 48.0k | ||||||||
Gross profit | 272.0k | 171.0k | 55.0k | 1.9m | ||||||||
General and administrative expense | 2.9m | 3.4m | 2.8m | 3.0m | 2.6m | 3.2m | 5.6m | 5.8m | 5.3m | 6.6m | 8.4m | 8.5m |
USD | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 | Q1, 2022 | Q2, 2022 | Q3, 2022 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 16.0m | 13.4m | 9.0m | 2.1m | 3.6m | 10.0m | 77.5m | 91.3m | 84.6m | 62.8m | 39.2m | 33.8m |
Accounts Receivable | 119.0k | 155.0k | 117.0k | 75.0k | 224.0k | 75.0k | 300.0k | 180.0k | 387.0k | 207.0k | 111.0k | 1.0m |
Prepaid Expenses | 206.0k | 396.0k | 432.0k | 183.0k | 146.0k | 189.0k | 263.0k | 1.9m | 2.5m | 1.7m | 2.9m | 2.3m |
Inventories | 843.0k | 1.1m | 587.0k | 2.0m | 3.3m |
USD | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 | Q1, 2022 | Q2, 2022 | Q3, 2022 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | (4.4m) | (8.9m) | (13.1m) | (4.5m) | (8.2m) | (12.9m) | (7.5m) | (15.7m) | (23.3m) | (8.9m) | (20.9m) | (33.2m) |
Depreciation and Amortization | 443.0k | 875.0k | 1.3m | 558.0k | 1.1m | 1.7m | 584.0k | 1.2m | 548.0k | 394.0k | 1.0m | 1.9m |
Inventories | (45.0k) | (273.0k) | ||||||||||
Accounts Payable | (16.0k) | (40.0k) | (29.0k) | (403.0k) | (549.0k) | (440.0k) | (12.0k) | 491.0k | (303.0k) | 79.0k | 872.0k | 1.6m |
USD | FY, 2018 |
---|---|
Revenue/Employee | 10.3k |
Debt/Equity | 1.6 x |
Debt/Assets | 0.6 x |
Financial Leverage | 2.7 x |
FY, 2016 | |
---|---|
Patents Issued | 67 |
Patents Pending | 19 |
iBio revenue breakdown by business segment: 94.4% from iBio, Inc. and 5.6% from iBio CDMO
iBio has 0 Twitter Followers. The number of followers has decreased 100% quarter over quarter
When was iBio founded?
iBio was founded in 2008.
Who are iBio key executives?
iBio's key executives are Thomas F. Isett, Martin B. Brenner and Randy J. Maddux.
How many employees does iBio have?
iBio has 51 employees.
What is iBio revenue?
Latest iBio annual revenue is $2.4 m.
What is iBio revenue per employee?
Latest iBio revenue per employee is $46.5 k.
Who are iBio competitors?
Competitors of iBio include Alvotech, Tedor Pharma and KBI Biopharma.
Where is iBio headquarters?
iBio headquarters is located at 8800 HSC Pkwy, Bryan.
Where are iBio offices?
iBio has an office in Bryan.
How many offices does iBio have?
iBio has 1 office.
Receive alerts for 300+ data fields across thousands of companies